| Advantages | These organoids provide a physiologically relevant platform for studying intrahepatic and extrahepatic cholangiocarcinoma, tumor progression, and chemoresistance. They are ideal for disease modeling, drug testing, and investigating therapeutic responses to agents. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Bile Duct |
| Disease | Cancer |
| Format | Frozen |
| Organoid Characterization | They retain the molecular characteristics and tumor heterogeneity of the original cancer, including key features such as IDH1/2 mutations, FGFR2 fusions, and cholangiocyte differentiation. |
| Applications | Tissue-derived organoids are extensively employed in drug screening, disease modeling, mechanistic research, personalized medicine, and regenerative medicine. Through faithful recapitulation of disease states, they offer an ideal platform for assessing patient-specific drug responses and facilitating personalized treatment design. Furthermore, these organoids support the development of novel therapeutic approaches, especially in oncology and organ regeneration, providing sophisticated experimental tools that accelerate progress in precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.